<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for EXAS</title>
    <link />
    <description>Headlines for EXACT Sciences Corp</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>EXACT Sciences (EXAS) Shares Cross Above 200 DMA</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923461/1/exact-sciences-exas-shares-cross-above-200-dma.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 14 May 2013 16:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Exact Sciences Is Poised to Underperform</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/why-exact-sciences-is-poised-to-underperform/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 17:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences to Participate in May Investor Conferences</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/exact-sciences-to-participate-in-may-investor-conf/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 10:50:12 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1391431-exact-sciences-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 17:40:05 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences Reports First-Quarter 2013 Financial Results, Announces Addition to Board of Director</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/exact-sciences-reports-first-quarter-2013-financia/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 07:50:53 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences to Host First-Quarter 2013 Results Webcast and Call</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/26/exact-sciences-to-host-first-quarter-2013-results-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 26 Apr 2013 13:27:36 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences' Cancer Test Won't Be A Commercial Success</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1355181-exact-sciences-cancer-test-won-t-be-a-commercial-success.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 19 Apr 2013 15:19:15 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Afternoon Market Update: Fairway Group Rises on Successful IPO as Markets Fall Further</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/04/3509516/mid-afternoon-market-update-fairway-group-rises-on-successful-ipo-as-mar.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 18 Apr 2013 15:43:57 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Afternoon Market Update: Fairway Group Rises on Successful IPO as Markets Fall Further</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/midafternoon-market-update-fairway-group-rises-on-successful-ipo-as-markets-fall-further-cm238390.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 18 Apr 2013 15:43:57 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences Corporation - Special Call</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1351641-exact-sciences-corporation-special-call.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 13:40:09 GMT</pubDate>
    </item>
    <item>
      <title>Why EXACT Sciences Shares Nosedived</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/18/why-exact-sciences-shares-nosedived/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 18 Apr 2013 13:24:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Day Market Update: Ultratech Tumbles On Downbeat Results, Theravance Rises</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/midday-market-update-ultratech-tumbles-on-downbeat-results-theravance-rises-cm238327.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 18 Apr 2013 13:11:30 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Day Market Update: Ultratech Tumbles On Downbeat Results, Theravance Rises</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/04/3508982/mid-day-market-update-ultratech-tumbles-on-downbeat-results-theravance-r.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 18 Apr 2013 13:11:30 GMT</pubDate>
    </item>
    <item>
      <title>EXACT Sciences Becomes Oversold (EXAS)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11899480/1/exact-sciences-becomes-oversold-exas.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 18 Apr 2013 12:36:00 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences Colon Cancer Screen Results Disappoint Wall Street.</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11898828/1/exact-sciences-colon-cancer-screen-results-disappoint-wall-street.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 18 Apr 2013 07:23:00 GMT</pubDate>
    </item>
    <item>
      <title>Top-Line Data Show Exact Sciences’ Cologuard Test Demonstrates 92 Percent Sensitivity in the Detecti</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/18/top-line-data-show-exact-sciences-cologuard-test-d/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 18 Apr 2013 06:16:52 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences Schedules Announcement and Call for Top-Line Results of DeeP-C Clinical Trial</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/17/exact-sciences-schedules-announcement-and-call-for/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 17 Apr 2013 19:05:12 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11893972/1/biotech-stock-mailbag-exact-sciences-galena-titan-arena-breakthrough-therapy.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 12 Apr 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Exact Sciences: A Cancer Diagnostic Play With An Upcoming Catalyst This Month</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1327911-exact-sciences-a-cancer-diagnostic-play-with-an-upcoming-catalyst-this-month.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 15:28:23 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: ARCP OPK EXAS</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11888586/1/cramers-top-stock-picks-arcp-opk-exas.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Sat, 06 Apr 2013 06:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
